A phase II study of isolated hepatic perfusion (IHP) with melphalan for metastatic unresectable cancers of the liver
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Melphalan (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 23 Mar 2012 Biomarkers information updated
- 22 Aug 2005 New trial record.